Fibromyalgia Treatment Market Size and Share Analysis Report: Forecast Trends and Outlook (2026-2035)

Key Trends in the Market

Fibromyalgia is defined as a musculoskeletal disorder which causes intense pain, fatigue, sleep, mood swings, headache, depression, and memory issues. This disorder increases the pain sensations to the brain and spinal cord. As there is no definitive cure, fibromyalgia treatment is aimed at providing comfort to the patients using medications and specialised drugs. Women are more susceptible to fibromyalgia.  

• The increasing prevalence of fibromyalgia, triggered by the sedentary lifestyles led by the working population, genetic predisposition, infections, and traumatic events in lives of people worldwide, is fuelling the fibromyalgia treatment market growth.

• Rising incidences of conditions such as lupus, rheumatoid arthritis, and osteoarthritis are leading to an increase in the number of cases of fibromyalgia, as patients with these conditions are more likely to develop fibromyalgia at some point in their lives.

• Over the forecast period, the anticipated increase in healthcare expenditure across the emerging economies, rising standards of living, and favourable policies of various governments are expected to improve the diagnosis and treatment infrastructure across the healthcare units, increasing the fibromyalgia treatment market size.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Segmentation

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Market Share by Drug Class

The antidepressant segment, based on drug class, accounts for a sizable fibromyalgia treatment market share. Antidepressants are an effective medication which reduces severe depression and feelings of trauma or exhaustion, while preventing their resurgence. Antidepressants are recommended by many doctors or pharmacists as they are safe and well-researched. In addition, these medicines can improve the quality of life by providing energy to carry out various day to day activities, which is expected to contribute to the fibromyalgia treatment market price. Meanwhile, the muscle relaxants segment is expected to witness a steady growth in the forecast period as it helps patients cope with muscle stress and tension. 

Market Share by Distribution Channel

As per the fibromyalgia treatment market report, the retail pharmacy segment accounts for a significant share of the market, based on distribution channel. This can be attributed to wider network and easier accessibility of retail pharmacies. Further, retail pharmacies bring greater convenience to people as it is usually available across remote and major locations in both urban and rural areas. Meanwhile, the online pharmacy segment is expected to register a decent growth in the forecast period due to the rising purchasing power and rapid digitalisation in the pharmaceutical and healthcare sector across the emerging economies. 

Competitive Landscape

Other market players include Allergan plc, Sun Pharmaceutical Industries Ltd, Intec Pharma Ltd, Astellas Pharma Inc, and Prismic Pharmaceuticals, Inc., among others.